The Appropriate Remifentanil Dose for Optimal Insertion of Laryngeal Mask Airway in Adult Patients During Induction of General Anesthesia Using Remimazolam.

NARecruitingINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

March 2, 2024

Primary Completion Date

July 29, 2025

Study Completion Date

July 29, 2025

Conditions
Adult, Laryngeal Masks, Remimazolam, Remifentanil
Interventions
DRUG

remifentanil of the assigned dose

Ambu Auragain will be inserted after general anesthesia is induced with remimazolam and remifentanil. Each patient will be assigned with a certain dose of remifentanil, according to whether the previous patient's LMA insertion process was successful or not.

DEVICE

Ambu Auragain for airway management

Ambu Auragain, a type of laryngeal mask airway, will be inserted into every patient after general anesthesia has been induced.

Trial Locations (1)

Unknown

RECRUITING

Severance Hospital, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER